Results 131 to 140 of about 159,387 (186)

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study. [PDF]

open access: yesClin Transl Oncol
Rodríguez-Lescure Á   +23 more
europepmc   +1 more source

Mortality related to multidrug-resistant microorganism infections: differentiating crude mortality from attributable mortality-author's reply. [PDF]

open access: yesLancet Reg Health Eur
Cisneros JM   +6 more
europepmc   +1 more source

Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. [PDF]

open access: yesWorld J Gastroenterol
Ruiz-Malagón AJ   +18 more
europepmc   +1 more source

Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care. [PDF]

open access: yesPharmaceutics
Lora-Escobar SJ   +14 more
europepmc   +1 more source

Cardiac rehabilitation for workers with ischemic heart disease: Benefits for cardiovascular health and quality of life. [PDF]

open access: yesMedicine (Baltimore)
Delgado-Calderón M   +8 more
europepmc   +1 more source

Effectiveness of antiemetic regimens in controlling chemotherapy induced nausea and vomiting during hematopoietic stem cell transplantation. [PDF]

open access: yesSci Rep
Suárez-Casillas P   +6 more
europepmc   +1 more source

Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients. [PDF]

open access: yesTranspl Int
García-Romero E   +21 more
europepmc   +1 more source

Impact of CMV-specific immune reconstitution at the end of letermovir prophylaxis on the development of late cytomegalovirus infection in haematopoietic stem cell transplant recipients (INMUNOEND): a protocol for a prospective, observational, multicentre study. [PDF]

open access: yesBMJ Open
Castón JJ   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy